Liberia vs Palestine, State of: Prevalence rate of hypertension in adults aged 30-79
Liberia
39.4
in 2019
Palestine, State of
39.1
in 2019
Liberia rank
85th
Palestine, State of rank
88th
Prevalence rate of hypertension in adults aged 30-79 over time
- Liberia
- Palestine, State of
How they compare
Liberia currently reports 39.4 against 39.1 in Palestine, State of, a difference of 0.3.
Across all 30 years both countries report, Liberia has been ahead every year.
Liberia ranks 85th and Palestine, State of ranks 88th of 194 countries.
Liberia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.84 | 38.46 | 0.38 | Liberia |
| 2000s | 40.75 | 40.06 | 0.69 | Liberia |
| 2010s | 40.35 | 39.73 | 0.62 | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Liberia or Palestine, State of?
- Liberia, at 39.4 against 39.1 in Palestine, State of as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Liberia and Palestine, State of?
- 0.3, with Liberia ahead.
- How many years of comparable data are there for Liberia and Palestine, State of?
- 30 years are reported by both, from 1990 to 2019.
- How do Liberia and Palestine, State of rank globally for prevalence rate of hypertension in adults aged 30-79?
- Liberia ranks 85th and Palestine, State of ranks 88th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.